Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Norwegian Centre for Integrated Care and Telemedicine | OTHER |
| Open-Evidence c/o Universitat Oberta de Catalunya | UNKNOWN |
| Institute for Health and Consumer Protection c/o University of Oslo, Faculty of Medicine |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the USECARE project is to improve and test SENACA, an ICT-based self-management support system for chronically ill patients and informal caregivers. 60 end-users will be instructed to use SENACA for approx. 3 months (in Israel and Norway). Amongst others, clinical and behavioural outcomes will be recorded. Additionally, SENACA's usability will be evaluated to determine its potential future scalability.
In Switzerland, SENior health ACAdemy (SENACA, www.senaca.ch) has been developed by the European Medical Network EMN.
SENACA is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. This online support system's usability, the behaviour change techniques it builds on, modes of delivery and its effects on health-related behaviour, clinical and Quality-of-Life outcomes will be established in a larger group of end-users.
Testing the usability of SENACA and practical effectiveness of this intervention is the goal of this multi-national project USECARE (www.usecare.eu).
SENACA will be implemented in two countries (Israel and Norway ) via field test with community-dwelling older adults living with chronic conditions (i.e. diabetes, COPD, chronic heart failure) and their informal caregivers.
Key element of USECARE is a field-test including a study based upon pre-experimental design with three time point measurements and a pre-usability round. Multiple methods will be used to evaluate the usability and to observe clinical and process parameters before, during and after the implementation of the enhanced SENACA prototype.
All of the results combined will provide an insight into the end-user experience, usage pattern, usability perception and potential added value of the enhanced SENACA prototype for chronic disease management in the participating countries.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SENACA - self-management support system | Experimental | Use of enhanced SENACA - ICT based self-management support system prototype by study participants at home for 75-100 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SENACA - ICT based self-management support system | Device | SENACA - ICT based self-management support system is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. ==> www.senaca.ch |
| Measure | Description | Time Frame |
|---|---|---|
| Level of and potential changes in technology acceptance in participants | Technology acceptance (usability) of system is measured by assessing participants' intention to use, perceived ease of use, perceived usefulness, technology experience, preference in using technology, errors, and user satisfaction. Instruments used are: Technology Acceptance Model (TAM), Post-Study System Usability Questionnaire (PSSUQ), all self-reported questionnaires. In addition, system errors will be reported (number and type of problems). | Up to three months |
| Measure | Description | Time Frame |
|---|---|---|
| Level of and potential changes in selected clinical outcomes of participants : BMI, weight, fasting glucose as well as HbA1c levels (sample) | Changes in selected clinical outcomes will be assessed with automated measurements via the intervention devices concerning body fat (fat proportion of body in %), body weight (in kg), blood pressure (systolic/diastolic in mmHg), pulse (per minute), SpO2 (in %) and fasting glucose (mmol). In Norway sample laboratory test will be conducted to determine levels of cholesterols (HDL, LDL in mmol), triglyceride (in mmol), HbA1c (mmol) and BNP (pg/ml). |
Not provided
Inclusion community-dwelling older adults (primary end-users):
receive medical care for one or more of the following chronic diseases in hospital settings and outpatient clinics:
having support of an informal caregiver that is aged 18 years or older
aged 50 years and older (primary end-users)
Exclusion community-dwelling older adults (primary end-users):
Inclusion informal caregivers (secondary end-users):
Both inclusion criteria primary and secondary end-users:
Both exclusion criteria primary and secondary end-users:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frank Larsen, MA | Norwegian Centre for Integrated Care and Telemedicine | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Assuta Medical Center | Tel Aviv | 69710 | Israel | |||
| University Hospital North Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
| European Medical Network EMN AG | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Up to three months |
| Level of and potential changes in health-related quality of life of participants assessed by EQ5D5L | Use of EQ-5DL a standardised instrument to measure health outcome and health-related quality of life. | Up to three months |
| Level of and potential changes in uptake and usage of the SENACA intervention by participants | Automated recording of relative frequency of usage of SENACA's modules (usage of single components that are not mandatory), adherence to SENACA (Number of days within program from initiation to discontinuation (time to event), errors of system during intervention (number and type of technical problems occurring) | Up to three months |
| Level of and potential changes in self-efficacy of participants | Measured with the Stanford Self-efficacy for managing chronic disease scale (SES6) | Up to three months |
| Level of and potential changes in health-related behaviour: nutrition & alcohol consumption, smoking, physical activity | Self-reported questionnaires on weekly unit consumption (nutrition/alcohol), exercise (in Norway) and walking (minutes or hours/week), smoking behaviour (tobacco products, consumption per day), alcohol (units/week).Physical activity will be recorded automatically via pedometer (device). | Up to three months |
| Level of and potential changes in eHealth Literacy in participants | eHealth Literacy is defined as the ability to read, use computers, search for information, understand health information, and put it into context.The eHealth Literacy Scale (eHEALS) as an 8-item measure will be used (self-reported questionnaire). | Up to three months |
| Tromsø |
| 9038 |
| Norway |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided